Back to top
more

Illumina (ILMN)

(Delayed Data from NSDQ)

$139.02 USD

139.02
2,616,684

+10.04 (7.78%)

Updated Oct 2, 2024 04:00 PM ET

After-Market: $139.40 +0.38 (0.27%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 252)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

LGND vs. ILMN: Which Stock Should Value Investors Buy Now?

LGND vs. ILMN: Which Stock Is the Better Value Option?

NVIDIA and Illumina have been highlighted as Zacks Bull and Bear of the Day

NVIDIA and Illumina are part of the Zacks Bull and Bear of the Day article.

Kevin Cook headshot

Bear of the Day: Illumina (ILMN)

Contracting margins, antitrust over GRAIL, and the Icahn invasion all crash estimates and shares

Charles River (CRL) Launches LVV-based Gene Therapy Platform

Charles River's (CRL) LVV platform provides medicinal developers with an efficient, dependable route to the clinic and the market.

Guardant Health (GH) Surges 8.8%: Is This an Indication of Further Gains?

Guardant Health (GH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Myriad Genetics (MYGN) Secures Key Milestones in Illumina Tie-Up

Myriad Genetics (MYGN) achieves significant milestones in its partnership with Illumina.

Illumina (ILMN) Down 14.2% Since Last Earnings Report: Can It Rebound?

Illumina (ILMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

EXEL vs. ILMN: Which Stock Is the Better Value Option?

EXEL vs. ILMN: Which Stock Is the Better Value Option?

Illumina (ILMN) Expands Presence in India With New Facility

Illumina (ILMN) boosts genomic capabilities in India with a new state-of-the-art Solutions Center.

EXEL or ILMN: Which Is the Better Value Stock Right Now?

EXEL vs. ILMN: Which Stock Is the Better Value Option?

Company News for Aug 11, 2023

Companies in The News Are: DDS,MFC,ILMN,G

Illumina (ILMN) Q2 Earnings Beat Estimates, Margins Contract

Illumina (ILMN) shipped 109 NovaSeq X instruments in the second quarter, boosting its supply capacity to more than 390 instruments for fiscal 2023.

Illumina (ILMN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Illumina (ILMN) Tops Q2 Earnings and Revenue Estimates

Illumina (ILMN) delivered earnings and revenue surprises of 1,500% and 1.11%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Illumina (ILMN) Soars 3.4%: Is Further Upside Left in the Stock?

Illumina (ILMN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Illumina's (ILMN) Latest Launch to Boost Genomics Analysis

Illumina's (ILMN) DRAGEN v4.2 is expected to improve the identification of genetic disease causes, drug discovery and population genomics.

LGND or ILMN: Which Is the Better Value Stock Right Now?

LGND vs. ILMN: Which Stock Is the Better Value Option?

LGND vs. ILMN: Which Stock Is the Better Value Option?

LGND vs. ILMN: Which Stock Is the Better Value Option?

Here's Why You Should Retain Illumina (ILMN) Stock for Now

Investors are optimistic about Illumina (ILMN) on solid long-term growth potential in the oncology space.

Illumina (ILMN) Sequencing Arm Grows, Margin Woes Linger

Illumina's (ILMN) total sequencing activity on connected high- and mid-throughput instruments are growing strongly.

LGND or ILMN: Which Is the Better Value Stock Right Now?

LGND vs. ILMN: Which Stock Is the Better Value Option?

Illumina's (ILMN) New AI Tool to Predict Genomics Disease

Illumina's (ILMN) PrimateAI-3D will be made broadly available to the genomics community integrated across Illumina Connected Software.

Why Is Horizon Therapeutics (HZNP) Down 9% Since Last Earnings Report?

Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Repligen (RGEN) Up 2.7% Since Last Earnings Report?

Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Illumina (ILMN) to Present Real-World CGP Data at ASCO Meet '23

At the ASCO meeting, Illumina (ILMN) is set to showcase data that highlights better outcomes for cancer patients who receive comprehensive genomic testing.